Yi-Jong Lin
Conseiller Juridique Général chez TaiGen Biotechnology Co., Ltd.
Profil
Yi-Jong Lin is a professional who currently holds the position of Vice President-Regulatory Affairs at TaiGen Biotechnology Co., Ltd.
Prior to this, he worked as a Principal at Colgate-Palmolive Co. and Eisai Medical Research, Inc. Dr. Lin received his graduate and doctorate degrees from the University of Tokyo.
Postes actifs de Yi-Jong Lin
| Sociétés | Poste | Début |
|---|---|---|
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Conseiller Juridique Général | 11/01/2010 |
Anciens postes connus de Yi-Jong Lin
| Sociétés | Poste | Fin |
|---|---|---|
| COLGATE-PALMOLIVE COMPANY | Corporate Officer/Principal | - |
| Eisai Medical Research, Inc. | Corporate Officer/Principal | - |
Formation de Yi-Jong Lin
| University of Tokyo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COLGATE-PALMOLIVE COMPANY | Consumer Non-Durables |
| Entreprise privées | 2 |
|---|---|
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
| Eisai Medical Research, Inc. |
